Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 5 | Arthritis Research & Therapy

Fig. 5

From: LNA-anti-miR-150 ameliorated kidney injury of lupus nephritis by inhibiting renal fibrosis and macrophage infiltration

Fig. 5

The effect of LNA-anti-miR-150 on renal SOCS1 in LN mice. a Renal mRNA levels of Socs1 determined by qPCR, b renal protein levels of Socs1 examined by western blotting and the density of the blots, and c immunoflurescent staining of Socs1 and its integrated optical density per area (IOD/area) in glomeruli (magnification × 400, bar = 30 μm) and the outer medulla (magnification × 200, bar = 100 μm) of paraffin-embedded kidney sections taken from WT and LN mice treated with the scrambled LNA or LNA-anti-miR-150 (subcutaneous injection twice weekly for 8 weeks). Data are expressed as mean ± SD from six mice per group. Statistical significance was determined using two-way ANOVA in a and t test in b, c (#p < 0.05, LN vs. WT; *p < 0.05, LNA-anti-miR-150 vs. the scrambled LNA)

Back to article page